This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Report Includes:
95 data tables
An overview of the global rheumatoid arthritis drugs market
Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
Identification of segments with high growth potential and their future applications
Explanation of major drivers and regional dynamics of the market and current trends within the industry
Key Topics Covered:
1 Introduction
2 Summary and Highlights
3 Drugs for Rheumatoid Arthritis Market Characteristics
4 Drugs for Rheumatoid Arthritis Market Size and Growth
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
5 Drugs for Rheumatoid Arthritis Market Trends and Strategies
Increasing Use of Technology
3D Printing Technologies
Combo and Mono Therapy
New Applications of NSAIDS
6 PESTLE Analysis
Political
Government Financial Support
Uncertain Political Policies
Economic
Wealth
Globalization
Emerging Markets
Social
Ageing Global Population
Sedentary Lifestyles
Health Consciousness and Awareness
Traditional Medicine Continues to Pose Threat to Market
Technological
3D Printing Technologies
Internet Penetration and Mobile Applications
Legal
Stringent Regulations and Long Approval Procedures
Investment Regulations
Patent Issues
Government Intervention
Environmental
7 Drugs for Rheumatoid Arthritis Market Segmentation
Global Drugs for Rheumatoid Arthritis Market, By Segment
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Market Characteristics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Market Characteristics
Corticosteroids
Market Characteristics
8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis
Global Drugs for Rheumatoid Arthritis Market, By Region
Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
Global Drugs for Rheumatoid Arthritis Market, By Country
Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors
Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
10 Asia-Pacific Drugs for Rheumatoid Arthritis Market
11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis
12 Western Europe Drugs for Rheumatoid Arthritis Market
13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
14 Eastern Europe Drugs for Rheumatoid Arthritis Market
15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
16 North America Drugs for Rheumatoid Arthritis Market
17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis18 South America Drugs for Rheumatoid Arthritis Market
19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis
20 Middle East Drugs for Rheumatoid Arthritis Market
21 Africa Drugs for Rheumatoid Arthritis Market
22 Drugs for Rheumatoid Arthritis Market Customer Information
Frequency of Pain after Treatment
Different Symptoms Experienced by Patients
Impact of Rheumatoid Arthritis at Workplace
Importance of Patient's Role in the Management of Rheumatoid Arthritis
Capacity of Affordable Treatment
23 Drugs for Rheumatoid Arthritis Market Competitive Landscape
Company Profiles
Abbvie Inc.
Amgen Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Pfizer
24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...
Adolescence isn't just a phase; it's a time of unparalleled growth and an opportunity for developing strengths that will influence our adult lives. Recognizing the potential of this developmental stage, Committee for Children a global nonprofit and...
The Prelude Network® (Prelude), the largest network of fertility clinics in North America, announced today an expansion of its partnership with Labcorp , a global leader of innovative diagnostic and biopharma laboratory services, to serve as its...
LISCure Biosciences, a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative microbiome-based therapies,...